孟鲁司特治疗毛细支气管炎92例的临床观察  

作　　者：胡大伟[1] 任东来[1] 

机构地区：[1]四川成都市大邑县人民医院儿科,611330

出　　处：《医学信息（下旬刊）》2011年第9期130-131,共2页Medical information

摘　　要：目的：观察孟鲁司特治疗呼吸道合胞病毒毛细支气管炎的效果.方法：92 例毛细支气管炎病儿随机分为两组.两组患儿均采用相同的综合性治疗,并给予布地奈德混悬液＋特布他林雾化吸入,治疗组在上述基础上加孟鲁司特4 mg,每晚睡前顿服.比较两组病儿疗效及症状、体征改善时间.结果：治疗组疗效优于对照组（χ2 = 10.54,P 〈 0.01）,治疗组病儿的症状、体征缓解时间明显短于对照组（t = 2.80～5.84,P 〈0.01）.结论：口服孟鲁司特治疗毛细支气管炎疗效确切,能缩短住院时间,且安全,应用方便.Objective：To investigate the curative effect of montelukast on respiratory syncytial virus bronchiolitis. Methods：92 cases of young patients with RSV bronchiolitis were randomly divided into two groups. The treatment group was given montelukast（4mg） in addition to conventional therapy and inhalation of Budesonide combined terbutaline, and the control group received routine therapy and inhalation of Budesonide combined terbutaline only. The curative effects were evaluated and compared. Results：The curative effect of treatment group was superior to that of control group（x2 = 10.54 , P 〈 0, 01 ） ,and the remission time of treatment group was significantly shorter than that of control group（t = 2. 80 ±5.84 , P 〈0,01 ）. Conclusions ： Oral administration of montelukast is effective, secure and convenient for treatment of patients with bronchiolitis.

关 键 词：孟鲁司特 毛细支气管炎 治疗结果 

分 类 号：R725.6[医药卫生—儿科]